Arcutis Biotherapeutics’ $150 Million Shares Offering

Laura Testa North America Legal Chronicle
Tagged:

Latham & Watkins advised Arcutis Biotherapeutics, Inc. in the offering, while Cooley represented the underwriters.Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) has announced the pricing of its underwritten public…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here